Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Int J Mol Sci ; 22(18)2021 Sep 13.
Article in English | MEDLINE | ID: covidwho-1409701

ABSTRACT

Takotsubo syndrome (TTS), recognized as stress's cardiomyopathy, or as left ventricular apical balloon syndrome in recent years, is a rare pathology, described for the first time by Japanese researchers in 1990. TTS is characterized by an interindividual heterogeneity in onset and progression, and by strong predominance in postmenopausal women. The clear causes of these TTS features are uncertain, given the limited understanding of this intriguing syndrome until now. However, the increasing frequency of TTS cases in recent years, and particularly correlated to the SARS-CoV-2 pandemic, leads us to the imperative necessity both of a complete knowledge of TTS pathophysiology for identifying biomarkers facilitating its management, and of targets for specific and effective treatments. The suspect of a genetic basis in TTS pathogenesis has been evidenced. Accordingly, familial forms of TTS have been described. However, a systematic and comprehensive characterization of the genetic or epigenetic factors significantly associated with TTS is lacking. Thus, we here conducted a systematic review of the literature before June 2021, to contribute to the identification of potential genetic and epigenetic factors associated with TTS. Interesting data were evidenced, but few in number and with diverse limitations. Consequently, we concluded that further work is needed to address the gaps discussed, and clear evidence may arrive by using multi-omics investigations.


Subject(s)
COVID-19/complications , Epigenesis, Genetic/immunology , Genetic Heterogeneity , Genetic Predisposition to Disease , Takotsubo Cardiomyopathy/genetics , Biomarkers/analysis , COVID-19/immunology , COVID-19/virology , DNA Copy Number Variations/immunology , Genetic Loci/immunology , Heart Ventricles/immunology , Heart Ventricles/pathology , Humans , Medical History Taking , Polymorphism, Single Nucleotide/immunology , SARS-CoV-2/immunology , Takotsubo Cardiomyopathy/diagnosis , Takotsubo Cardiomyopathy/immunology , Takotsubo Cardiomyopathy/pathology
2.
Cardiovasc Pathol ; 51: 107314, 2021.
Article in English | MEDLINE | ID: covidwho-947147

ABSTRACT

COVID-19 can involve several organs and systems, often with indirect and poorly clarified mechanisms. Different presentations of myocardial injury have been reported, with variable degrees of severity, often impacting on the prognosis of COVID-19 patients. The pathogenic mechanisms underlying cardiac damage in SARS-CoV-2 infection are under active investigation. We report the clinical and autopsy findings of a fatal case of Takotsubo Syndrome occurring in an 83-year-old patient with COVID-19 pneumonia. The patient was admitted to Emergency Department with dyspnea, fever and diarrhea. A naso-pharyngeal swab test for SARS-CoV-2 was positive. In the following week his conditions worsened, requiring intubation and deep sedation. While in the ICU, the patient suddenly showed ST segment elevation. Left ventricular angiography showed decreased with hypercontractile ventricular bases and mid-apical ballooning, consistent with diagnosis of Takotsubo syndrome. Shortly after the patient was pulseless. After extensive resuscitation maneuvers, the patient was declared dead. Autopsy revealed a subepicardial hematoma, in absence of myocardial rupture. On histology, the myocardium showed diffuse edema, multiple foci of contraction band necrosis in both ventricles and occasional coagulative necrosis of single cardiac myocytes. Abundant macrophages CD68+ were detected in the myocardial interstitium. The finding of diffuse contraction band necrosis supports the pathogenic role of increased catecholamine levels; the presence of a significant interstitial inflammatory infiltrate, made up by macrophages, remains of uncertain significance.


Subject(s)
COVID-19/complications , Myocardium/pathology , Takotsubo Cardiomyopathy/etiology , Aged, 80 and over , Autopsy , Biopsy , COVID-19/diagnosis , COVID-19/therapy , COVID-19 Nucleic Acid Testing , Fatal Outcome , Humans , Male , Takotsubo Cardiomyopathy/pathology , Takotsubo Cardiomyopathy/therapy
SELECTION OF CITATIONS
SEARCH DETAIL